Obesity, overweight and liver disease in the Midspan prospective cohort studies

International Journal of Obesity

Volumn 34, Issue 6, 2010, Pages 1051-1059

  Hart, C L ^a   Batty, G D ^b   Morrison, D S ^a   Mitchell, R J ^a   Smith, G Davey ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b MRC SOCIAL AND PUBLIC HEALTH SCIENCES UNIT   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Liver disease; Overweight; Prospective cohort studies; Scotland

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CANCER REGISTRY; COHORT ANALYSIS; DEATH CERTIFICATE; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; LIVER CANCER; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM; WORKPLACE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CONFIDENCE INTERVALS; FEMALE; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SCOTLAND; SMOKING; YOUNG ADULT;

EID: 77953609876     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2010.20     Document Type: Article

References (31)

1. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950-2002: an analysis of routine data. Lancet 2006; 367: 52-56.
2. Griffiths C, Brock A. Twentieth century mortality trends in England and Wales. Health Stat Q 2003; 18: 5-17.
3. Leyland AH, Dundas R, McLoone P, Boddy FA. Inequalities in Mortality in Scotland 1981-2001 (Occasional Paper No. 16). Glasgow: UK MRC Social and Public Health Sciences Unit, 2007.
4. Health in Scotland 2007. Annual Report of the Chief Medical Officer. Scottish Government 2008 http://www.scotland.gov.uk/Publications/2008/11/ 26155748/0
5. The Scottish Health Survey 2003 Volume2: Adults. Bromley C, Sproston K, Shelton N 2005, htttp://www.scotland.gov.uk/Resource/Doc/76169/0019729.pdf.
6. Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab 2008; 993: S74-S80.
7. Olsen AH, Parkin DM, Sasieni P. Cancer mortality in the United Kingdom: projections to the year 2025. Br J Cancer 2008; 99: 1549-1554.
8. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007; 97: 1005-1008. (Pubitemid 47519294)
9. Ioannou GN, Weiss NS, Kowdley KV, Dominitz JA. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 2003; 125: 1053-1059.
10. Batty GD, Shipley MJ, Kivimaki M, Barzi F, Davey Smith G, Mitchell R et al. Obesity and overweight in relation to liver disease mortality in men: 38 year follow-up of the original Whitehall study. Int J Obes 2008; 32: 1741-1744.
11. Hart CL, MacKinnon PL, Watt GCM, Upton MN, McConnachie A, Hole DJ et al. The Midspan studies. Int J Epidemiol 2005; 34: 28-34.
12. Hawthorne VM, Gillis CR, Lorimer AR, Calvert FR, Walker TJ. Blood pressure in a Scottish island community. BMJ 1969; 4: 654.
13. Davey Smith G, Hart C, Hole D, MacKinnon P, Gillis C, Watt G et al. Education and occupational social class: which is the more important indicator of mortality risk? J Epidemiol Community Health 1998; 52: 153-160.
14. Hawthorne VM, Watt GCM, Hart CL, Hole DJ, Davey Smith G, Gillis CR. Cardiorespiratory disease in men and women in urban Scotland: baseline characteristics of the Renfrew/Paisley (Mid-span) Study population. Scott Med J 1995; 40: 102-107.
15. General Register Office. Classification of Occupations 1960. HMSO: London, 1960; 1-136.
16. General Register Office. Classification of Occupations 1966. HMSO: London, 1966; 1-148.
17. Medical Research Council. Definition and classification of chronic bronchitis for epidemiological purposes. Lancet 1965; i: 775-779.
18. Rose GA, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular Survey Methods. World Health Organization: Geneva, 1982.
19. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. John Wright: Littleton, MA, 1982; 1-229.
20. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
21. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-1231.
22. Brunt EM. Pathology of fatty liver disease. Mod Pathol 2007; 20: S40-S48.
23. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-923.
24. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ et al. Association of non-alcoholic fatty liver disease with insulin resistance. Am J Med 1999; 107: 450-455.
25. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-1395.
26. Williams R. Global challenges in liver disease. Hepatology 2006; 44: 521-526
27. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR: Washington DC, 2007.
28. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625-1638.
29. Bolton-Smith C, Woodward M, Tunstall-Pedoe H, Morrison C. Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health 2000; 54: 143-148.
30. Dauphinot V, Wolff H, Naudin F, Gueguen R, Sermet C, Gaspoz J et al. New obesity body mass index threshold for self-reported data. J Epidemiol Community Health 2009; 63: 128-132.
31. Obesity in Scotland. An epidemiology briefing. Grant I, Fischbacher C, Whyte B 2007. http://www.scotpho.org.uk/nmsruntime/saveasdialog.asp? lID4048&sID 348.